Large drugmakers to be hit by double punishment

Korea’s large drug makers are struggling to cope with sluggish sales of their flagship products as external environments are harsh and gloomy.

These days, pharmaceutical companies face the government’s intensive campaigns aimed at curbing rebates and lowering drug prices.

Last August the Ministry of Health and Welfare launched a crackdown on unlawful drug marketing activities. It introdu...